Medical Dynamics

Xanodyne wins $50 million in financing (Business Courier of Cincinnati)

Shot supply to shrink (Mississauga News)

Setting the standards for pharmacy (PJ Online)

Read the rest of this entry »

Glaxo gives price pledge as malaria shot holds hope (Reuters)

Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois (Abbott)

Bristol-Myers Squibb Donation to Benefit Students at The Pennington School and Beyond (Reuters)

Pair Of Potential Obesity Drugs Show Promise In Phase III Trials (Healthnewsdaily)

ActivaCro christens inVentiv Clinical Global Alliance (pharmatimes)

GAO Accuses FDA of Tardy Trial Data (pharmexec.com)

AstraZeneca sales boosted by swine flu vaccine (pharmatimes)

Aldagen mounts fresh attempt to pull off an IPO (fiercebiotech)

Priority Of Merck’s Integration Of Schering Is Retaining Top R&D Talent, Kim Says (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Genomics Revolution Meets Regulatory Evolution: Why Personalized Medicine Is Taking So Long (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

12% growth for ICON’s operating income in Q2 (pharmatimes)

Novartis Prepares For Diovan Patent Expiries; Looks To New Product Launches (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Getting Past FDA’s HALT: Can Amgen Escape New Trial Requirement For Prolia With Data From SRE Studies? (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Comparative Effectiveness: Pharma Needs To Take Charge, Quintiles Says (Pinksheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

UK trust sues Amgen, Wyeth over Enbrel patent (Reuters)

Pfizer, Indian NGO tie up on public health (RxPGnes)

Watson, Barr settle patent dispute (Drugstorenews)

Obama girls get H1N1 vaccinations amid shortages; Peramivir approved by FDA (Examiner)

Microbix plans huge new vax facility; Novartis wins Ilaris approval (FierceBiotech)

Novartis Champions Renewable Energy With New Vacaville Solar Array (Reuters)

Genomics Revolution Meets Regulatory Evolution: Why Personalized Medicine Is Taking So Long (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010 (PR Newswire)

UPDATE 1-Glaxo starts late-stage tests with ‘Son of Advair’ (Reuters)

Why is Pharma Betting So Big on Innovation in Boston? (XConomy)

Gene therapy offers hope for severe hereditary eye disease (KNOE, Channel 8 News)

New Studies Demonstrate Benefits of Minimally Invasive Hysterectomy and Colectomy When Compared to Open Surgery (Reuters)

J&J CEO’s Lower-Risk Alternative to Acquisitions (Wall Street Journal)

FDA doesn’t act on post-marketing data (Fierce Pharma)

Read the rest of this entry »

More PML cases prompt Europe’s regulators to review Tysabri (Pharma Times)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Healthcare system wastes up to $800 billion a year (Reuters)

EU Approval For Movetis’ Resolor Validates Its Targeted Strategy in GI Disorders (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Read the rest of this entry »

Novartis Gets Complete Response Letter from FDA for Investigational Bronchodilator QAB149 (Therapeutics Dailly)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Merck & Co earnings climb as Januvia and Isentress impress (Pharma Times)

US pharma lobbying bill soars (Pharma Times)

Read the rest of this entry »

DB Schenker to Distribute Systagenix Products (Journal of Commerce)

Five Red Flags of a Biotech, Pathway Medical Learns Lessons,

Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News (Seattle Pi)

Medco trial to explore genetic impact on Plavix versus Effient (Pharma Times)

Read the rest of this entry »